
Anantaa GSK Itechnology Private Limited
About Anantaa GSK Itechnology Private Limited
Data last updated:
Anantaa GSK Itechnology Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 12 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52311DL2021PTC383568.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Aarchin Gsk Private Limited. It is led by directors Arti Sharma and Hemant Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 4/1 Phase – 2 Okhla Industrial Area, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.55 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.32 Lakh (net margin -5.8%) and EBITDA of ₹49,005 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 374% over three years.
The company is associated with 1 brand: Aarchin.
Anantaa GSK Itechnology Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0020452).
Company details
Recognitions & Rankings of Anantaa GSK Itechnology
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-08-0020452
Contact details
Anantaa GSK Itechnology Private Limited's registered office is in Delhi, Delhi.
- Registered AddressD – 4/1 Phase – 2 Okhla Industrial Area, Delhi, India – 110020
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Anantaa GSK Itechnology operates one associated brand: Aarchin. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform for medical devices, pharmaceuticals, and health supplements sales. | aarchin.com |
Business activity
The main business activity of Anantaa GSK Itechnology is manufacturing. In detail, this covers computer, electronic, communication and scientific measuring & control equipment.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C9 | Computer, electronic, Communication and scientific measuring & control equipment |
To see the full business activity and turnover split of Anantaa GSK Itechnology Private Limited, buy the company report.
Financials of Anantaa GSK Itechnology Private Limited
FY 2025 filings availableAnantaa GSK Itechnology Private Limited reported revenue of ₹22.55 Lakh (up 546% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 374% over three years, including 546% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹49,005 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.32 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.2% | |||
| Net Profit Margin | -5.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Anantaa GSK Itechnology Private Limited, buy the company report.
Board of directors of Anantaa GSK Itechnology Private Limited
Anantaa GSK Itechnology has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arti Sharma | Director | 12 Jul 2021 | 5 Years 4 Months | Current |
| Hemant Kumar Sharma | Director | 12 Jul 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Anantaa GSK Itechnology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anantaa GSK Itechnology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Anantaa GSK Itechnology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Anantaa GSK Itechnology Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Arti Sharma was appointed as Director on 12 Jul 2021.
Frequently asked questions
Anantaa GSK Itechnology is an active private limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 12 July 2021 (5+ years old) and is registered under CIN U52311DL2021PTC383568.
Anantaa GSK Itechnology has 2 current directors:
- Arti Sharma - Director
- Hemant Kumar Sharma - Director
The latest financial statements of Anantaa GSK Itechnology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Anantaa GSK Itechnology is U52311DL2021PTC383568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anantaa GSK Itechnology was incorporated on 12 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Arti Sharma was appointed as Director on 12 Jul 2021. Hemant Kumar Sharma was appointed as Director on 12 Jul 2021.
Yes, Anantaa GSK Itechnology is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Anantaa GSK Itechnology is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0020452).
The registered office of Anantaa GSK Itechnology is at D – 41 Phase – 2 Okhla Industrial Area, Delhi, India – 110020.
Anantaa GSK Itechnology operates in the healthcare industry, in the medical and laboratory equipment segment.

